Clinical Trials Logo

Stage I Adult Hodgkin Lymphoma clinical trials

View clinical trials related to Stage I Adult Hodgkin Lymphoma.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02343666 Withdrawn - Clinical trials for Stage IV Adult Hodgkin Lymphoma

HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection

Start date: August 15, 2016
Phase: Phase 1
Study type: Interventional

This pilot phase I trial studies the side effects and best dose of human immunodeficiency virus (HIV)-resistant gene modified stem cells in treating HIV-positive patients who are undergoing first-line treatment for Hodgkin or Non-Hodgkin Lymphoma. Stem cells are collected from the patient and HIV-resistance genes are placed into the stem cells. The stem cells are then re-infused into the patient. These genetically modified stem cells may help the body make cells that are resistant to HIV infection.

NCT ID: NCT01165645 Withdrawn - Hodgkin Lymphoma Clinical Trials

Lopinavir and Ritonavir in Improving Immune Response to Vaccines in Patients With Complete Remission Following A Bone Marrow Transplant for Hodgkin Lymphoma

Start date: November 2010
Phase: N/A
Study type: Interventional

RATIONALE: HIV protease inhibitors, including Lopinavir/Ritonavir have intrinsic anti-apoptotic properties in addition to their anti-viral effect on HIV. This anti-apoptotic effect may boost the immune system to help the body create a better immune response to vaccines. PURPOSE: This randomized clinical trial studies giving lopinavir and ritonavir together in improving immune response to vaccines in patients with complete remission following a bone marrow transplant for Hodgkin lymphoma.